Proteomic Profiling Informs Mechanisms of Esophageal Adenocarcinoma Inhibition by Cranberry ProanthocyanidinsYun Zhang(University of Michigan), Laura A. Kresty(Medical College of Wisconsin)Molecular Nutrition & Food ResearchMay 12, 202510.1002/mnfr.70102Cited by 3SaveCiteExport RISWatch citationsRelated PapersCranberry proanthocyanidins inhibit esophageal adenocarcinoma <i>in vitro</i> and <i>in vivo</i> through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation|Oncotarget|2015|66Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights|Nutrients|2022|16Disparities in Head and Neck Cancer: A Case for Chemoprevention with Vitamin D|Nutrients|2020|8Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model|Pharmaceuticals|2023|4